Insulin increases ceramide synthesis in skeletal muscle

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Hansen, M E ^a   Tippetts, T S ^a   Anderson, M C ^a   Holub, Z E ^a   Moulton, E R ^a   Swensen, A C ^b   Prince, J T ^b   Bikman, B T ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL ACYLTRANSFERASE 1; INSULIN; PALMITIC ACID; SERINE PALMITOYLTRANSFERASE SUBUNIT 1; SERINE PALMITOYLTRANSFERASE SUBUNIT 2; SPHINGOLIPID; SPHINGOLIPID DELTA(4) DESATURASE; TRANSFERASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHAPERONE; LIPID; PALMITIC ACID DERIVATIVE; SPT2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; CERAMIDE METABOLISM; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; SOLEUS MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CHEMISTRY; CYTOLOGY; MYOBLAST; POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CERAMIDES; HISTONE CHAPERONES; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOBLASTS; PALMITATES; POLYMERASE CHAIN REACTION; SPHINGOLIPIDS;

EID: 84902206970     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/765784     Document Type: Article

References (63)

1. Pories W. J., Dohm G. L., Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 2012 35 12 2438 2442 10.2337/dc12-0684
2. Reaven G. M., Hollenbeck C., Jeng C.-Y., Wu M. S., Chen Y.-D. I., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988 37 8 1020 1024 2-s2.0-0024244339 (Pubitemid 19033579)
3. Das A. K., Shah S., History of diabetes: from ants to analogs. The Journal of the Association of Physicians of India 2011 59 6 7 2-s2.0-80051566008
4. McGarry J. D., What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992 258 5083 766 770 2-s2.0-0026468362
5. Chavez J. A., Summers S. A., Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochimica et Biophysica Acta 2010 1801 3 252 265 2-s2.0-76049095119 10.1016/j.bbalip.2009.09.015
6. Shanik M. H., Xu Y., Skrha J., Dankner R., Zick Y., Roth J., Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008 31 supplement 2 S262 S268 2-s2.0-41149159084
7. Currie C. J., Peters J. R., Tynan A., Evans M., Heine R. J., Bracco O. L., Zagar T., Poole C. D., Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. The Lancet 2010 375 9713 481 489 2-s2.0-75749145810 10.1016/S0140-6736(09)61969-3
8. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S., Insulin resistance in essential hypertension. The New England Journal of Medicine 1987 317 6 350 357 (Pubitemid 17118813)
9. Utzschneider K. M., Kahn S. E., Review: the role of insulin resistance in nonalcoholic fatty liver disease. The Journal of Clinical Endocrinology and Metabolism 2006 91 12 4753 4761 2-s2.0-33845490856 10.1210/jc.2006-0587 (Pubitemid 44917301)
10. Bikman B. T., Summers S. A., Sphingolipids and hepatic steatosis. Advances in Experimental Medicine and Biology 2011 721 87 97 2-s2.0-80053616691 10.1007/978-1-4614-0650-1-6
11. Dunaif A., Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 6 774 800 (Pubitemid 28009567)
12. Watson G. S., Craft S., The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 2003 17 1 27 45 2-s2.0-0037221379 10.2165/00023210-200317010-00003 (Pubitemid 36044347)
13. Murakami K., Shigematsu Y., Hamada M., Higaki J., Insulin resistance in patients with hypertrophic cardiomyopthy. Circulation Journal 2004 68 7 650 655 2-s2.0-3142766836 10.1253/circj.68.650 (Pubitemid 38906627)
14. Guillet C., Boirie Y., Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes & Metabolism 2005 31 2 S20 S26 2-s2.0-30844447721
15. DeFronzo R. A., Ferrannini E., Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 14 3 173 194 2-s2.0-0026021161
16. Haus J. M., Kashyap S. R., Kasumov T., Zhang R., Kelly K. R., Defronzo R. A., Kirwan J. P., Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009 58 2 337 343 2-s2.0-63249117466 10.2337/db08-1228
17. Spijkers L. J. A., van den Akker R. F. P., Janssen B. J. A., Debets J. J., de Mey J. G. R., Stroes E. S. G., van den Born B.-J. H., Wijesinghe D. S., Chalfant C. E., MacAleese L., Eijkel G. B., Heeren R. M. A., Alewijnse A. E., Peters S. L. M., Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide. PLoS ONE 2011 6 7 2-s2.0-79960449880 10.1371/journal.pone.0021817 e21817
18. Marks N., Berg M. J., Saito M., Saito M., Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: consequences to morphology and viability on enzyme suppression in cultured primary neurons. Brain Research 2008 1191 136 147 2-s2.0-38349051098 10.1016/j.brainres.2007.10.066
19. Cutler R. G., Kelly J., Storie K., Pedersen W. A., Tammara A., Hatanpaa K., Troncoso J. C., Mattson M. P., Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2070 2075 2-s2.0-1242338183 10.1073/pnas.0305799101 (Pubitemid 38229016)
20. Holland W. L., Bikman B. T., Wang L.-P., Yuguang G., Sargent K. M., Bulchand S., Knotts T. A., Shui G., Clegg D. J., Wenk M. R., Pagliassotti M. J., Scherer P. E., Summers S. A., Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. The Journal of Clinical Investigation 2011 121 5 1858 1870 2-s2.0-79955487247 10.1172/JCI43378
21. Holland W. L., Brozinick J. T., Wang L.-P., Hawkins E. D., Sargent K. M., Liu Y., Narra K., Hoehn K. L., Knotts T. A., Siesky A., Nelson D. H., Karathanasis S. K., Fontenot G., Birnbaum M. J., Summers S. A., Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metabolism 2007 5 3 167 179 2-s2.0-33847332202 10.1016/j.cmet.2007.01.002
22. Hill J. W., Elias C. F., Fukuda M., Williams K. W., Berglund E. D., Holland W. L., Cho Y.-R., Chuang J.-C., Xu Y., Choi M., Lauzon D., Lee C. E., Coppari R., Richardson J. A., Zigman J. M., Chua S., Scherer P. E., Lowell B. B., Brüning J. C., Elmquist J. K., Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metabolism 2010 11 4 286 297 2-s2.0-77950264425 10.1016/j.cmet.2010.03.002
23. Smith M. E., Tippetts T. S., Brassfield E. S., Tucker B. J., Ockey A., Swensen A. C., Anthonymuthu T. S., Washburn T. D., Kane D. A., Prince J. T., Bikman B. T., Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle. The Biochemical Journal 2013 456 427 439 10.1042/BJ20130807
24. Bikman B. T., Summers S. A., Ceramides as modulators of cellular and whole-body metabolism. The Journal of Clinical Investigation 2011 121 11 4222 4230 2-s2.0-80555124939 10.1172/JCI57144
25. Bikman B. T., A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cellular and molecular life sciences. Cellular and Molecular Life Sciences 2012 69 13 2135 2146 10.1007/s00018-012-0917-5
26. Commerford S. R., Peng L., Dubé J. J., O'Doherty R. M., In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2004 287 1 R218 R227 2-s2.0-3042846012 10.1152/ajpregu.00377.2003 (Pubitemid 38856330)
27. Guillet-Deniau I., Mieulet V., Lay S. L., Achouri Y., Carré D., Girard J., Foufelle F., Ferré P., Sterol regulatory element binding protein-1c expression and action in rat muscles: Insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 2002 51 6 1722 1728 2-s2.0-0036259860 (Pubitemid 34564283)
28. Srinivasan K., Ramarao P., Animal models in type 2 diabetes research: an overview. The Indian Journal of Medical Research 2007 125 3 451 472 2-s2.0-34249279490 (Pubitemid 46805458)
29. Fraser D. A., Thoen J., Rustan A. C., Førre Ø., Kjeldsen-Kragh J., Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation. Rheumatology 1999 38 10 948 952 2-s2.0-0032702547 10.1093/rheumatology/38.10.948 (Pubitemid 29505075)
30. Fahy E., Subramaniam S., Murphy R. C., Nishijima M., Raetz C. R. H., Shimizu T., Spener F., van Meer G., Wakelam M. J. O., Dennis E. A., Update of the LIPID MAPS comprehensive classification system for lipids. Journal of Lipid Research 2009 50 S9 S14 2-s2.0-66349098682 10.1194/jlr.R800095-JLR200
31. Erickson K. A., Smith M. E., Anthonymuthu T. S., Evanson M. J., Brassfield E. S., Hodson A. E., Bressler M. A., Tucker B. J., Thatcher M. O., Prince J. T., Hancock C. R., Bikman B. T., AICAR inhibits ceramide biosynthesis in skeletal muscle. Diabetology & Metabolic Syndrome 2012 4 1, article 45 10.1186/1758-5996-4-45
32. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001 29 9, article e45 2-s2.0-17344392308
33. Bikman B. T., Guan Y., Shui G., Siddique M. M., Holland W. L., Kim J. Y., Fabrias G., Wenk M. R., Summers S. A., Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. The Journal of Biological Chemistry 2012 287 21 17426 17437 10.1074/jbc.M112.359950
34. Adams J. M. II, Pratipanawatr T., Berria R., Wang E., DeFronzo R. A., Sullards M. C., Mandarino L. J., Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004 53 1 25 31 2-s2.0-0346729968 10.2337/diabetes.53.1.25 (Pubitemid 38044694)
35. Straczkowski M., Kowalska I., Baranowski M., Nikolajuk A., Otziomek E., Zabielski P., Adamska A., Blachnio A., Gorski J., Gorska M., Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 2007 50 11 2366 2373 2-s2.0-34848921862 10.1007/s00125-007-0781-2 (Pubitemid 47512392)
36. Coen P. M., Dubé J. J., Amati F., Stefanovic-Racic M., Ferrell R. E., Toledo F. G. S., Goodpaster B. H., Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010 59 1 80 88 2-s2.0-77449161528 10.2337/db09-0988
37. Chavez J. A., Knotts T. A., Wang L.-P., Li G., Dobrowsky R. T., Florant G. L., Summers S. A., A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. The Journal of Biological Chemistry 2003 278 12 10297 10303 2-s2.0-0038532298 10.1074/jbc.M212307200 (Pubitemid 36800291)
38. Schmitz-Peiffer C., Craig D. L., Biden T. J., Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. The Journal of Biological Chemistry 1999 274 34 24202 24210 2-s2.0-0033588253 10.1074/jbc.274.34.24202 (Pubitemid 29390356)
39. Amati F., Dubé J. J., Alvarez-Carnero E., Edreira M. M., Chomentowski P., Coen P. M., Switzer G. E., Bickel P. E., Stefanovic-Racic M., Toledo F. G. S., Goodpaster B. H., Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 2011 60 10 2588 2597 2-s2.0-80053403320 10.2337/db10-1221
40. Holland W. L., Miller R. A., Wang Z. V., Sun K., Barth B. M., Bui H. H., Davis K. E., Bikman B. T., Halberg N., Rutkowski J. M., Wade M. R., Tenorio V. M., Kuo M.-S., Brozinick J. T., Zhang B. B., Birnbaum M. J., Summers S. A., Scherer P. E., Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine 2011 17 1 55 63 2-s2.0-78651260799 10.1038/nm.2277
41. Zabielski P., Blachnio-Zabielska A. U., Lanza I. R., Gopala S., Manjunatha S., Jakaitis D. R., Persson X. M., Gransee J., Klaus K. A., Coenen-Schimke J. M., Jensen M. D., Nair K. S., Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice. American Journal of Physiology Endocrinology and Metabolism 2013 10.1152/ajpendo.00610.2012
42. Goodpaster B. H., He J., Watkins S., Kelley D. E., Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. The Journal of Clinical Endocrinology and Metabolism 2001 86 12 5755 5761 2-s2.0-0035217707 10.1210/jc.86.12.5755 (Pubitemid 33152620)
43. Liu L., Zhang Y., Chen N., Shi X., Tsang B., Yu Y.-H., Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. The Journal of Clinical Investigation 2007 117 6 1679 1689 2-s2.0-34249894505 10.1172/JCI30565 (Pubitemid 46871352)
44. Lopez-Velazquez J. A., Carrillo-Cordova L. D., Chavez-Tapia N. C., Uribe M., Mendez-Sanchez N., Nuclear receptors in nonalcoholic Fatty liver disease. Journal of Lipids 2012 2012 10 139875 10.1155/2012/139875
45. Li S., Brown M. S., Goldstein J. L., Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 8 3441 3446 2-s2.0-77649264504 10.1073/pnas.0914798107
46. Facchini F. S., Hua N., Abbasi F., Reaven G. M., Insulin resistance as a predictor of age-related diseases. The Journal of Clinical Endocrinology and Metabolism 2001 86 8 3574 3578 2-s2.0-0034891371 10.1210/jc.86.8.3574 (Pubitemid 32755946)
47. Deckert T., Poulsen J. E., Larsen M., Prognosis of diabetics with diabetes onset before the age of thirtyone. II. Factors influencing the prognosis. Diabetologia 1978 14 6 371 377 2-s2.0-0018140662 (Pubitemid 8357141)
48. Hotamisligil G. S., Peraldi P., Budavari A., Ellis R., White M. F., Spiegelman B. M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996 271 5249 665 668 10.1126/science.271.5249.665 (Pubitemid 26052915)
49. Velasquez-Mieyer P. A., Cowan P. A., Arheart K. L., Buffington C. K., Spencer K. A., Connelly B. E., Cowan G. W., Lustig R. H., Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults. International Journal of Obesity 2003 27 2 219 226 2-s2.0-0013102988 10.1038/sj.ijo.802227 (Pubitemid 36255804)
50. King B. M., Smith R. L., Frohman L. A., Hyperinsulinemia in rats with ventromedial hypothalamic lesions: role of hyperphagia. Behavioral Neuroscience 1984 98 1 152 155 2-s2.0-0021330994 10.1037//0735-7044.98.1.152 (Pubitemid 14174065)
51. Hustvedt B. E., Lovo A., Correlation between hyperinsulinemia and hyperphagia in rats with ventromedial hypothalamic lesions. Acta Physiologica Scandinavica 1972 84 1 29 33 2-s2.0-0015266939
52. Carlson M. G., Campbell P. J., Intensive insulin therapy and weight gain in IDDM. Diabetes 1993 42 12 1700 1707 2-s2.0-0027517779 (Pubitemid 23346405)
53. Mäkimattila S., Nikkilä K., Yki-Järvinen H., Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia 1999 42 4 406 412 2-s2.0-0344609217 10.1007/s001250051172 (Pubitemid 29148398)
54. Torbay N., Bracco E. F., Geliebter A., Stewart I. M., Hashim S. A., Insulin increases body fat despite control of food intake and physical activity. The American Journal of Physiology 1985 248 1, part 2 R120 R124 2-s2.0-0021986027 (Pubitemid 15172502)
55. Cox J. E., Powley T. L., Development of obesity in diabetic mice pair fed with lean siblings. Journal of Comparative and Physiological Psychology 1977 91 2 347 358 2-s2.0-0017578054 (Pubitemid 8087578)
56. Nathan D. M., Buse J. B., Davidson M. B., Ferrannini E., Holman R. R., Sherwin R., Zinman B., American Diabetes A., Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009 32 1 193 203 10.2337/dc08-9025
57. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2010 33 supplement 1 S62 S69 10.2337/dc10-S062
58. Yancy W. S. Jr., Foy M., Chalecki A. M., Vernon M. C., Westman E. C., A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutrition & Metabolism 2005 2, article 34 2-s2.0-30344462964 10.1186/1743-7075-2-34 (Pubitemid 43060608)
59. Stout R. W., Insulin-stimulated lipogenesis in arterial tissue in relation to diabetes and atheroma. The Lancet 1968 2 7570 702 703 2-s2.0-0014433315
60. Bismuth J., Lin P., Yao Q., Chen C., Ceramide: a common pathway for atherosclerosis? Atherosclerosis 2008 196 2 497 504 2-s2.0-38349092384 10.1016/j.atherosclerosis.2007.09.018
61. Reaven G. M., Lithell H., Landsberg L., Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. The New England Journal of Medicine 1996 334 6 374 381 10.1056/NEJM199602083340607 (Pubitemid 26049592)
62. Zhang D. X., Zou A.-P., Li P.-L., Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries. Circulation Research 2001 88 8 824 831 2-s2.0-0035957592 (Pubitemid 32429979)
63. Zhang Q. J., Holland W. L., Wilson L., Tanner J. M., Kearns D., Cahoon J. M., Pettey D., Losee J., Duncan B., Gale D., Kowalski C. A., Deeter N., Nichols A., Deesing M., Arrant C., Ruan T., Boehme C., McCamey D. R., Rou J., Ambal K., Narra K. K., Summers S. A., Abel E. D., Symons J. D., Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 2012 61 7 1848 1859 10.2337/db11-1399